Indivior Pharmaceuticals, Inc. (INDV)

34.95 +0.08 (+0.23%) USD  |  NASDAQ  |  Aug 31, 16:00
34.95 0.00 (0.00%) After-Hours: 19:22
More

Indivior Pharmaceuticals Total Long Term Debt (Quarterly) : 500.00M for June 30, 2026

Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for INDV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 500.00M
March 31, 2026 500.00M
December 31, 2025 341.00M
September 30, 2025 346.00M
June 30, 2025 355.00M
March 31, 2025 359.00M
December 31, 2024 365.00M
September 30, 2024 284.00M
June 30, 2024 281.00M
March 31, 2024 279.00M
December 31, 2023 282.00M
September 30, 2023 277.00M
June 30, 2023 281.00M
March 31, 2023 279.00M
December 31, 2022 277.00M
September 30, 2022 276.00M
June 30, 2022 280.00M
March 31, 2022 282.00M
December 31, 2021 286.00M
September 30, 2021 288.00M
June 30, 2021 290.00M
March 31, 2021 282.00M
December 31, 2020 285.00M
Date Value
September 30, 2020 283.00M
June 30, 2020 284.00M
March 31, 2020 285.00M
December 31, 2019 293.00M
September 30, 2019 292.00M
June 30, 2019 295.00M
March 31, 2019 297.00M
December 31, 2018 241.00M
September 30, 2018 324.00M
June 30, 2018 472.00M
March 31, 2018 478.00M
December 31, 2017 482.00M
September 30, 2017 341.00M
June 30, 2017 352.00M
March 31, 2017 423.00M
December 31, 2016 535.00M
September 30, 2016 546.00M
June 30, 2016 551.00M
March 31, 2016 542.00M
December 31, 2015 605.00M
September 30, 2015 528.00M
June 30, 2015 541.00M
March 31, 2015 669.00M

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Supernus Pharmaceuticals, Inc. 29.43M
Liquidia Corp. 182.90M
Corcept Therapeutics, Inc. 7.504M
Prestige Consumer Healthcare, Inc. 2.057B
Harrow, Inc. 299.80M